Note 6 - Fair Value Measurements - Assets Measured at Fair Value on Nonrecurring Basis (Details) - USD ($) |
3 Months Ended | 12 Months Ended | |
|---|---|---|---|
Sep. 30, 2022 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Impairment, Long-Lived Asset, Held-for-Use, Total | $ 3,762,915 | $ 0 | |
| Goodwill, Impairment Loss | $ 2,254,624 | 6,460,168 | 0 |
| Fair Value, Nonrecurring [Member] | |||
| Intangible assets | 3,649,193 | 0 | |
| Impairment of Right of Use Assets | 113,722 | 0 | |
| Impairment, Long-Lived Asset, Held-for-Use, Total | 3,762,915 | 0 | |
| Goodwill, Impairment Loss | 6,460,168 | 0 | |
| Total | $ 10,223,083 | $ 0 | |
| X | ||||||||||
- Definition Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Represents the impairment of right-of-use assets. No definition available.
|
| X | ||||||||||
- Details
|